Join NAMSA for this webinar as we discuss strategies to optimize your preclinical testing with an emphasis on complex Class II and Class III medical devices focused in the cardiovascular therapeutic area. Highlighted will be an overview of cardiovascular device conceptualization, prototype and iterative design, model selection and how to build a foolproof pivotal safety-testing plan.
Every regulatory group is in agreement. Cleaning begins at the point-of-use. So why is it so hard to maintain compliance with this very simple and well-known standard? In this webinar, Healthmark Clinical Education Specialist, Malinda Elammari, will attempt to show the how and why of point-of-use cleaning as well as the vital role it plays in patient safety. This presentation will also give strategies for maintaining compliance over the long term. SPD, OR, Endoscopy, & IP professionals, pay attention!
The MedTech Conference will bring together the world's top medtech executives and innovators for three days of programs, networking and business development opportunities. The MedTech Conference will be held in person in Boston, MA! Options for virtual attendance are also available to ensure maximum participation from the global medtech community. No matter how you participate, you are guaranteed to experience the same quality programming and networking that you’ve come to expect from The MedTech Conference.
The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering the Combination Products Summit. The AFDO/RAPS Healthcare Products Collaborative combination products community continues to be led by top FDA officials and worldwide industry leaders who built the framework for the regulatory landscape of combination products. This global community drives innovation and navigates the complexities specific to the world of combination products, resulting in the delivery of safe, effective, and high-quality products to the patients who need them.
The Advancing Healthcare Innovation Summit (AHIS2022) is a major healthcare conference and exhibit showcasing the latest innovations related to healthcare and medical sciences. AHIS2022 is a networking conference for all stakeholders in healthcare innovations.
Join us for an exciting announcement about the organization's next evolution. Ohio’s life sciences industry is on the precipice of a generational opportunity to deliver on the promise of economic advancement and well-being for our state’s residents, and accelerate Ohio’s national leadership in this arena. Join life sciences industry leaders and elected officials for a special event on November 17th. You’ll learn about our next evolution in advancing innovation and advocating for the common interests across Ohio’s life sciences community. This includes a new, cross-sector effort to accelerate workforce development that will be a central fuel for progress, today and for the future. Limited space available – RSVP today to secure your spot! There will be time for networking after the presentation concludes.
The Ohio Chamber is holding its inaugural Healthcare Transformation Summit. The summit will bring together stakeholders across the healthcare industry to discuss current challenges, successes, and innovations for tomorrow that will transform healthcare services in order to create a system that is less costly and produces better outcomes for Ohioans. The Summit includes keynote speakers and 17 different panel discussions including topics on access and affordability, workforce development, price transparency, infant mortality and behavioral health. This is a one-day event, with registration opening at 8:30 a.m., the summit starting at 9:30 a.m. and the event ending at 4:00 p.m. BioOhio will be participating in the panel on Workforce Development in Healthcare.
Healthcare diagnostics has seen a significant increase in over-the-counter (OTC) or direct-to-consumer (DTC) testing. A trajectory that was already in the making prior to COVID-19, this area has increased at a faster pace as more consumers are comfortable performing OTC tests at home. This change in consumer expectation, as well as an evolution of global regulatory requirements, has led to increased considerations and requirements by IVD manufacturers to produce robust testing options. Join NAMSA for this webinar as we evaluate those enhanced requirements specifically as they affect human factors and usability engineering to ensure all IVDs are safe and effective for the intended users, uses and use environments. Early understanding of these requirements is crucial and can influence the device display, controls, functions, results interpretations, instructions and countless other design inputs impacting the consumer.
Ohio Life Sciences has relaunched with a focus on advancing innovation and advocating for the common interests across Ohio’s life sciences community. This includes a new, cross-sector effort to accelerate workforce development that will be a central fuel for progress, today and for the future. OLS is excited to convene our regional life sciences communities across the state and continue to share our mission and build member investor engagement. During this networking event, we will facilitate open dialogue and brainstorming on workforce development opportunities across the state, as well as ways you can get involved to unify industry and education to grow Ohio's life sciences workforce. This FREE event will be hosted by OLS member Dupler Office. Drinks and appetizers will be provided.
Join NAMSA for this webinar where we will discuss the most common approaches used for determining the exhaustive endpoint, their advantages and disadvantages and their influence on study design and results. We will also outline how regulatory requirements and laboratory execution diverge, as well as other challenges of an E&L study that are influenced by a lack of standardized procedures (e.g. mass balance, toxicological assessment).
